Department of Special Surgery, Jordan University Hospital, Amman 11942, Jordan.
Department of Pathology and Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan.
Genes (Basel). 2022 Nov 23;13(12):2192. doi: 10.3390/genes13122192.
is one of the most common genes causing autosomal recessive non-syndromic sensorineural hearing loss (SNHL). It has been reported to cause Pendred Syndrome (PDS) and DFNB4 which is deafness with enlarged vestibular aqueduct (EVA). However, mutated is not conclusive for having either DFNB4 or PDS. Three unrelated Jordanian families consisting of eight affected individuals with congenital bilateral hearing loss (HL) participated in this study. Whole-exome and Sanger sequencing were performed to investigate the underlying molecular etiology of HL. Further clinical investigations, including laboratory blood workup for the thyroid gland, CT scan for the temporal bone, and thyroid ultrasound were performed. Three disease-causing variants were identified in in the three families, two of which were novel. Two families had a novel pathogenic homozygous splice-site accepter variant (c.165-1G>C), while the third family had compound heterozygous pathogenic variants (c.1446G>A; p.Trp482* and c.304G>A; p.Gly102Arg). Our approach helped in redirecting the diagnosis of several affected members of three different families from non-syndromic HL to syndromic HL. Two of the affected individuals had typical PDS, one had DFNB4, while the rest had atypical PDS. Our work emphasized the intra- and inter-familial variability of -related phenotypes. In addition, we highlighted the variable phenotypic impact of on tailoring a personalized healthcare management.
是导致常染色体隐性非综合征型感觉神经性耳聋(SNHL)的最常见基因之一。它已被报道可导致帕登氏综合征(PDS)和耳聋伴扩大的内淋巴管(EVA)的 DFNB4。然而,突变 对于患有 DFNB4 或 PDS 并不具有决定性。三个无关联的约旦家族,共 8 名患有先天性双侧听力损失(HL)的受影响个体参与了这项研究。进行了外显子组和 Sanger 测序,以调查 HL 的潜在分子病因。进一步的临床调查,包括甲状腺的实验室血液检查、颞骨 CT 扫描和甲状腺超声检查。在这三个家庭中,共发现了 中的三个致病变异,其中两个是新的。两个家庭有一个新的致病纯合剪接受体位点变异(c.165-1G>C),而第三个家庭有复合杂合致病变异(c.1446G>A;p.Trp482*和 c.304G>A;p.Gly102Arg)。我们的方法有助于将三个不同家庭的多个受影响成员的非综合征性 HL 诊断重新导向为综合征性 HL。其中两个受影响的个体有典型的 PDS,一个有 DFNB4,而其余的有非典型的 PDS。我们的工作强调了 相关表型的个体内和个体间变异性。此外,我们强调了 对制定个性化医疗保健管理的表型影响的可变性。